This inventor holds 3 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Korea Institute of Geoscience and Mineral Resources. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: The Innovative Contributions of Il Mo Kang
Introduction
Il Mo Kang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of drug delivery systems, particularly through his innovative patents. With a total of 3 patents, Kang's work focuses on enhancing the bioavailability of pharmaceutical compounds.
Latest Patents
Kang's latest patents include a "Drug-clay mineral complex containing phospholipid and oral administration composition including same." This invention provides a drug-clay mineral complex that comprises a phospholipid, where the drug has an amine group. Another notable patent is the "Drug and layered silicate composite with improved oral bioavailability, oral pharmacological composition containing the composite and method for producing the composite." This patent describes a composite that significantly improves the absorption and bioavailability of a sorafenib compound, utilizing layered silicate powders and a drug compound bound between the layers.
Career Highlights
Il Mo Kang is affiliated with the Korea Institute of Geoscience and Mineral Resources. His work at this institution has allowed him to explore innovative solutions in drug formulation and delivery, contributing to advancements in medical science.
Collaborations
Kang has collaborated with notable colleagues such as Ki Min Roh and Jae Hwan Kim. These partnerships have fostered a collaborative environment that enhances research and development in their respective fields.
Conclusion
Il Mo Kang's innovative patents and contributions to drug delivery systems highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments and drug formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
